Ujiri Pharmaceuticals Private Limited
About Ujiri Pharmaceuticals Private Limited
Data last updated:
Ujiri Pharmaceuticals Private Limited is a private limited company based in Faridabad, Haryana, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 11 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U51909HR2017PTC070717. Its GSTIN is 06AACCU1417A1Z1 (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gaurav Tanwar and Pavneesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Col. Vihar Bharat Colony, Faridabad, Haryana, India – 121002.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.21 Lakh, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹11,768 (net margin 0.8%) and EBITDA of ₹81,899 (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 15% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ujiri Pharmaceuticals Private Limited's registered office is in Faridabad, Haryana. Its e-mail address is in the company report.
- Email
- Registered AddressCol. Vihar Bharat Colony, Faridabad, Haryana, India – 121002
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Ujiri Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ujiri Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ujiri Pharmaceuticals Private Limited, buy the company report.
Financials of Ujiri Pharmaceuticals Private Limited
FY 2025 filings availableUjiri Pharmaceuticals Private Limited reported revenue of ₹15.21 Lakh (down 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 17% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 15%. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹81,899 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹11,768 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ujiri Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ujiri Pharmaceuticals Private Limited
Ujiri Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gaurav Tanwar | Director | 11 Sep 2017 | 9 Years 1 Months | Current |
| Pavneesh Kumar | Director | 11 Sep 2017 | 9 Years 1 Months | Current |
Peer comparison
Ujiri Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cato Pharmaceuticals Private Limited | ₹15.29 Lakh (FY 2018) | Kakinada, Andhra Pradesh, India | ||||
| Attentiva Pharmaceuticals Private Limited | ₹15.25 Lakh (FY 2025) | -30.0% | Ranchi, Jharkhand, India | |||
| Panorama Pharmaceuticals Private Limited | ₹15.24 Lakh (FY 2024) | -41.0% | Hyderabad, Telangana, India | |||
| Ujiri Pharmaceuticals Private Limitedthis company | ₹15.21 Lakh (FY 2025) | ₹11,768 | 0.8% | -17.0% | Faridabad, Haryana, India | |
| Bluefinch Pharmaceuticals Private Limited | ₹15.09 Lakh (FY 2025) | -3.0% | Kolkata, West Bengal, India | |||
| Moon Rock Pharmaceuticals Private Limited | ₹15.08 Lakh (FY 2025) | 21.0% | Jind, Haryana, India |
To see the full peer comparison of Ujiri Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ujiri Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ujiri Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ujiri Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AACCU1417A1Z1 | Haryana | Active | 09 Jan 2018 |
To see the full GST registrations and return filing status of Ujiri Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ujiri Pharmaceuticals Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Gaurav Tanwar was appointed as Director on 11 Sep 2017.
Frequently asked questions
Ujiri Pharmaceuticals is an active private limited company based in Faridabad, Haryana, India. The company works in specialty, within the trading industry. It was incorporated on 11 September 2017 (9+ years old) and is registered under CIN U51909HR2017PTC070717.
Ujiri Pharmaceuticals has 2 current directors:
- Gaurav Tanwar - Director
- Pavneesh Kumar - Director
The latest financial statements of Ujiri Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Ujiri Pharmaceuticals is 06AACCU1417A1Z1, registered in Haryana.
The CIN (Corporate Identification Number) of Ujiri Pharmaceuticals is U51909HR2017PTC070717. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ujiri Pharmaceuticals was incorporated on 11 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Ujiri Pharmaceuticals by revenue are Cato Pharmaceuticals Private Limited, Attentiva Pharmaceuticals Private Limited, Panorama Pharmaceuticals Private Limited, Bluefinch Pharmaceuticals Private Limited, Moon Rock Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Gaurav Tanwar was appointed as Director on 11 Sep 2017. Pavneesh Kumar was appointed as Director on 11 Sep 2017.
The registered office of Ujiri Pharmaceuticals is at Col. Vihar Bharat Colony, Faridabad, Haryana, India – 121002.
Ujiri Pharmaceuticals operates in the trading industry, in the specialty segment.
The compliance status of Ujiri Pharmaceuticals is compliant as of 29 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
